DK116659B - Fremgangsmåde til fremstilling af 9α-hydroxy-11β-nitro-1,3,5(10)-østratriener. - Google Patents
Fremgangsmåde til fremstilling af 9α-hydroxy-11β-nitro-1,3,5(10)-østratriener.Info
- Publication number
- DK116659B DK116659B DK569867AA DK569867A DK116659B DK 116659 B DK116659 B DK 116659B DK 569867A A DK569867A A DK 569867AA DK 569867 A DK569867 A DK 569867A DK 116659 B DK116659 B DK 116659B
- Authority
- DK
- Denmark
- Prior art keywords
- estratrienes
- nitro
- hydroxy
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT3007766 | 1966-11-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK116659B true DK116659B (da) | 1970-02-02 |
Family
ID=11228982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK569867AA DK116659B (da) | 1966-11-18 | 1967-11-15 | Fremgangsmåde til fremstilling af 9α-hydroxy-11β-nitro-1,3,5(10)-østratriener. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US3520909A (da) |
| AT (1) | AT271757B (da) |
| BE (1) | BE706686A (da) |
| CH (1) | CH493506A (da) |
| DE (1) | DE1618977B1 (da) |
| DK (1) | DK116659B (da) |
| ES (1) | ES347318A1 (da) |
| FR (1) | FR7064M (da) |
| GB (1) | GB1145437A (da) |
| GR (1) | GR38947B (da) |
| IL (1) | IL28936A (da) |
| NL (2) | NL6715106A (da) |
| NO (1) | NO128023B (da) |
| SE (1) | SE335527B (da) |
| YU (1) | YU31806B (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5554603A (en) * | 1993-09-17 | 1996-09-10 | The United States Of America As Represented By The Department Of Health And Human Services | Orally active derivatives of 1,3,5(10)-estratriene |
-
0
- NL NL135316D patent/NL135316C/xx active
-
1967
- 1967-11-07 NL NL6715106A patent/NL6715106A/xx unknown
- 1967-11-13 DE DE1967S0112800 patent/DE1618977B1/de not_active Withdrawn
- 1967-11-13 IL IL28936A patent/IL28936A/en unknown
- 1967-11-14 FR FR128076A patent/FR7064M/fr not_active Expired
- 1967-11-14 GB GB51714/67A patent/GB1145437A/en not_active Expired
- 1967-11-14 AT AT1024767A patent/AT271757B/de active
- 1967-11-15 YU YU2225/67A patent/YU31806B/xx unknown
- 1967-11-15 DK DK569867AA patent/DK116659B/da unknown
- 1967-11-17 BE BE706686D patent/BE706686A/xx unknown
- 1967-11-17 CH CH1615667A patent/CH493506A/de not_active IP Right Cessation
- 1967-11-17 GR GR670138947A patent/GR38947B/el unknown
- 1967-11-17 SE SE15811/67A patent/SE335527B/xx unknown
- 1967-11-17 ES ES347318A patent/ES347318A1/es not_active Expired
- 1967-11-17 NO NO00170574A patent/NO128023B/no unknown
-
1969
- 1969-02-28 US US803415*A patent/US3520909A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| NL6715106A (da) | 1968-05-20 |
| CH493506A (de) | 1970-07-15 |
| SE335527B (da) | 1971-06-01 |
| ES347318A1 (es) | 1969-02-01 |
| NL135316C (da) | |
| GR38947B (el) | 1970-01-20 |
| US3520909A (en) | 1970-07-21 |
| YU31806B (en) | 1973-12-31 |
| GB1145437A (en) | 1969-03-12 |
| FR7064M (da) | 1969-06-23 |
| AT271757B (de) | 1969-06-10 |
| BE706686A (da) | 1968-05-17 |
| YU222567A (en) | 1973-06-30 |
| IL28936A (en) | 1972-07-26 |
| DE1618977B1 (de) | 1972-07-20 |
| NO128023B (da) | 1973-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK120546B (da) | Fremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimidiner. | |
| DK118877B (da) | Analogifremgangsmåde til fremstilling af 3,1-benzoxazin-2-oner. | |
| DK119005B (da) | Fremgangsmåde til fremstilling af 3-alkoxy-13-alkylgona-1,3,5(10),8,14-penten-17-oner. | |
| DK112523B (da) | Fremgangsmåde til fremstilling af 2,3-pyridindiol. | |
| DK114556B (da) | Fremgangsmåde til fremstilling af 1,4-benzodiazepin-2-on-4-oxider. | |
| DK116357B (da) | Fremgangsmåde til fremstilling af 1,1,1,2,2-pentafluor-3-chlorpropan. | |
| DK115184B (da) | Fremgangsmåde til fremstilling af 6,7-benzomorphaner. | |
| DK123169B (da) | Fremgangsmåde til fremstilling af 2,5-dichlor-4-alkylmercaptophenoler. | |
| DK114273B (da) | Fremgangsmåde til fremstilling af α-methyl-α-amino-β-(3,4-disubstituerede-phenyl)-propionitriler. | |
| DK120131B (da) | Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener. | |
| DK115622B (da) | Fremgangsmåde til fremstilling af 3-oxogona-4,9,11-triener. | |
| DK116594B (da) | Fremgangsmåde til fremstilling af 4,1,5-benzoxadiazociner. | |
| DK126936B (da) | Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener. | |
| DK118406B (da) | Fremgangsmåde til fremstilling af 3-alkynyloxy- og 3-alkenyloxy-4-sulfanilamido-1,2,5-thiadiazoler. | |
| DK112031B (da) | Fremgangsmåde til fremstilling af 3,20-dioxo-17α-methyl-19-nor-pregna-4,9,11-trien. | |
| DK127418B (da) | Fremgangsmåde til fremstilling af 13-alkyl-gona-1,3,5(10),6,8,14-hexaener. | |
| DK117955B (da) | Analogifremgangsmåde til fremstilling af N<4>-acrylerede 1-halogenbenzen-2,4-disulfonamider. | |
| DK120845B (da) | Fremgangsmåde til fremstilling af 3β-formoxy-15α-halogen-14β-hydroxy-5β-card-20(22)-enolider. | |
| DK116368B (da) | Fremgangsmåde til fremstilling af 2,3-dihydro-2,2,4-trimethyl-7-benzofuranol. | |
| DK113917B (da) | Fremgangsmåde til fremstilling af 2,2,6,6-tetrachlorcyclohexanon. | |
| DK116659B (da) | Fremgangsmåde til fremstilling af 9α-hydroxy-11β-nitro-1,3,5(10)-østratriener. | |
| DK119108B (da) | Fremgangsmåde til fremstilling af C-D-trans-3-hydroxy-13-alkyl-17-oxogona-1,3,5(10),6,8-pentener. | |
| DK126688B (da) | Fremgangsmåde til fremstilling af 13-alkyl-gona-1,3,5(10),7-tetraener. | |
| DK127327B (da) | Fremgangsmåde til fremstilling af 1,2,3,4-tetrahydronaphthalen-2-on-derivater. | |
| DK122389B (da) | Analogifremgangsmåde til fremstilling af chlorbenzen-2,4-disulfonamider. |